Rocuronium Injection, Solution
Product Images NDC 71872-7349

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 71872-7349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7349m.pdp (7349)

7349m.pdp (7349)
Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) in a 10 mL multi-dose vial, labeled for intravenous use. The label includes warnings about paralysis and respiratory arrest, storage instructions to keep refrigerated, and manufacturer information for Medical Purchasing Solutions, LLC, Scottsdale, AZ. The NDC is 71872-7349.*
FDA Label Image

7349m.pdp (7349m)

7349m.pdp (7349m)
Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) solution for intravenous use. The label indicates it is a 10 mL multi-dose vial, prescription only. It includes warnings about paralyzing effects and instructions for dosage, storage, and manufacturing details by Medical Purchasing Solutions, LLC, with additional manufacturer information from Pirmal Critical Care and Sanovel IlaƧ San. The label also features a barcode and batch information.*
FDA Label Image

Structure (Rocuronium Structure)

Structure (Rocuronium Structure)
Chemical structure of rocuronium, showing its molecular configuration including the steroid nucleus, quaternary ammonium group, and other functional groups relevant to its formulation as an intravenous injection solution.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A box plot chart showing the distribution of a variable measured in minutes across different age groups (18-64 years, 65 years and older, and 1-12 years) and dosages (mg/kg). The x-axis represents dosage and age group categories, while the y-axis indicates time in minutes. Data points and box whiskers suggest variability in measurements.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A box-and-whisker plot displaying distribution of a variable measured in minutes across different age groups and doses in mg/kg. Age groups include 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. Dose levels range from 0.45 to 1.2 mg/kg depending on the age group. The vertical axis represents time in minutes.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph depicting time in minutes on the vertical axis against dose number on the horizontal axis. It shows two plotted lines comparing the effects of doses at 0.1 mg/kg and 0.15 mg/kg, with sample sizes of N=29 and N=13 respectively.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.